AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2019

Nov 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK: 0001439222
Period of Report: 2019-11-13

Reporting Person: Schenkein David P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-13	Common stock	P	8064	$31	Acquired	97567	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	270772	Indirect
Common stock	79082	Indirect

Footnotes

F1: All shares were purchased at $31.00 per share in an underwritten public offering that closed on November 13, 2019.

F2: Shares held by David P. Schenkein 2004 Revocable Trust, of which the reporting person is trustee and beneficiary.

F3: Shares held by Amy P. Schenkein 2004 Revocable Trust, of which the reporting person's spouse is trustee and beneficiary.